Medical Devices; Radiology Devices; Classification of the Radiological Machine Learning-Based Quantitative Imaging Software With Predetermined Change Control Plan
- When
- · day precision
- Where
- United States, US
- Category
- government_regulation · rule
The Food and Drug Administration (FDA) is classifying the radiological machine learning-based quantitative imaging software with predetermined change control plan into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the radiological machine learning-based quantitative imaging software with predetermined change control plan. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Involved actors & entities
People, organizations and places machine-extracted from the source reporting — they power search and the correlation graph. Extracted automatically, so they can include noise, especially on events still marked unverified.
Sources
- Health and Human Services Department ↗ · first seen 2026-06-17 00:00 UTC
Defaxon links out to the original reporting and never republishes article text.
Correlated events
Computed by the Defaxon correlation engine — linked by shared actors, co-location, and temporal proximity. Scored hypotheses, never causal claims.